Liutti VT, do Vale DL, de Souza BL, Manea RRF, et al. Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 2025 Jun 13. doi: 10.1007/s10549-025-07746.
PMID: 40512324